CAS No.: 1239278-59-1
Tanimilast Catalog No. CSN20279
Synonyms: CHF-6001;tanimilast;tanimilastum
CHF-6001 is a PDE4 inhibitor designed for treating pulmonary inflammatory diseases via inhaled administration.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT01730404 COPD Phase 2 Completed - Ireland ... more >> Celerion Belfast, Ireland United Kingdom Parexel, early phases Harrow, United Kingdom Medicines Evaluation Unit Ltd Manchester, United Kingdom Freeman Hospital Newcastle, United Kingdom Nottingham University Hospitals NHS Trust Nottingham, United Kingdom Collapse << NCT03004495 Copd Phase 1 Completed - United Kingdom ... more >> Quintiles CPU London, UK, United Kingdom, SE1 1 YR Collapse << NCT02986321 Chronic Obstructive Pulmonary ... more >>Disease Collapse << Phase 2 Completed - - - 更多
- 参考文献
- [1] Kistemaker LE, Oenema TA, et al. The PDE4 inhibitor CHF-6001 and LAMAs inhibit bronchoconstriction-induced remodelling in lung slices. Am J Physiol Lung Cell Mol Physiol. 2017 Jun 8:ajplung.00069.2017.
- [2] Matera MG, Page C, Cazzola M. PDE inhibitors currently in early clinical trials for the treatment of asthma. Expert Opin Investig Drugs. 2014 Sep;23(9):1267-75.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1239278-59-1 | 储存条件 |
|
|
| 分子式 | C30H30Cl2F2N2O8S | 运输 | 蓝冰 | |
| 分子量 | 687.54 | 别名 | CHF-6001;tanimilast;tanimilastum |
